Sales of breast implants linked to cancer to be suspended in Canada
The move against Allergan's Biocell breast implants comes after an ongoing safety review.
Canada's health regulator said Thursday that it is advising Allergan that it intends to suspend the licences for Biocell breast implants as a precautionary measure.
Health Canada said its move followed the completion of its assessment of textured breast implants as part of a larger ongoing safety review of breast implants. -- More...
Read Full Article...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy